Thanks for the concise and systematic point by point study @kpax. Going by your analysis, CNM-Au8 is very much a work in progress, unlike our monepantel pill - which has a fast-acting and very effective role in up-regulating the autophagy process that is needed as part of the treatment of MND/ALS, and most probably of other neurodegenerative diseases and a number of cancers (the latter is already proven in the lab with 28 types of human tumours) - something PharmAust needs to highlight to the investing public. PharmAust's monepantel pill, with its proven up-regulation of the much needed autophagy process with minimal side effects, is the current global gold standard for this purpose, and fearing that some highly specialised treatment like CNM-Au8 is going to suddenly make it redundant is mistaken (or so it seems to me).
Cheers
- Forums
- ASX - By Stock
- NUZ
- Latest MND Webinar information on Monepantel
NUZ
neurizon therapeutics limited
Add to My Watchlist
7.69%
!
12.0¢

Latest MND Webinar information on Monepantel, page-34
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
12.0¢ |
Change
-0.010(7.69%) |
Mkt cap ! $59.07M |
Open | High | Low | Value | Volume |
12.5¢ | 12.5¢ | 12.0¢ | $31.03K | 257.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 57583 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 109056 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 57583 | 0.115 |
6 | 50975 | 0.110 |
3 | 48000 | 0.105 |
6 | 395757 | 0.100 |
1 | 10000 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 109056 | 3 |
0.130 | 1590 | 2 |
0.135 | 18407 | 2 |
0.140 | 219705 | 3 |
0.145 | 490000 | 2 |
Last trade - 13.02pm 03/04/2025 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |